AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia
暂无分享,去创建一个
[1] D. Diz,et al. Activation of Local Chorionic Villi Angiotensin II Levels But Not Angiotensin (1-7) in Preeclampsia , 2008, Hypertension.
[2] S. Ramin,et al. Potential Roles of Angiotensin Receptor-Activating Autoantibody in the Pathophysiology of Preeclampsia , 2007, Hypertension.
[3] M. Wolf,et al. Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia , 2007, Hypertension.
[4] G. Wallukat,et al. Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia , 2007, Hypertension.
[5] Asif Ahmed,et al. Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in Pregnancy , 2007, Circulation research.
[6] A. Germain,et al. Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation , 2001, Endocrine.
[7] G. Wallukat,et al. Agonistic autoantibodies to the AT1 receptor in rat models of preeclampsia: induced by chronic reductions in uterine perfusion pressure (RUPP) and low dose TNFalpha infusion , 2006 .
[8] M. Lindheimer,et al. Explaining and predicting preeclampsia. , 2006, The New England journal of medicine.
[9] G. Wallukat,et al. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. , 2006, The Journal of clinical endocrinology and metabolism.
[10] T. Libermann,et al. Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.
[11] D. Shah. The role of RAS in the pathogenesis of preeclampsia , 2006, Current hypertension reports.
[12] James M. Roberts,et al. Preeclampsia: recent insights. , 2005, Hypertension.
[13] G. Wallukat,et al. Angiotensin II Type 1 Receptor Agonistic Antibodies Reflect Fundamental Alterations in the Uteroplacental Vasculature , 2005, Hypertension.
[14] Megumi Tanaka,et al. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. , 2005, Endocrine journal.
[15] I. Sargent,et al. Latest Advances in Understanding Preeclampsia , 2005, Science.
[16] J. Wetzels,et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. , 2005, The New England journal of medicine.
[17] G. Wallukat,et al. Agonistic Autoantibodies to the AT1 Receptor in a Transgenic Rat Model of Preeclampsia , 2005, Hypertension.
[18] J. Ingelfinger. Agonistic autoantibodies and rejection of renal allografts. , 2005, The New England journal of medicine.
[19] J. Ernerudh,et al. Immunology of preeclampsia. , 2005, Chemical immunology and allergy.
[20] L. Poston,et al. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. , 2004, Hypertension.
[21] L. Gilstrap,et al. Antibodies From Preeclamptic Patients Stimulate Increased Intracellular Ca2+ Mobilization Through Angiotensin Receptor Activation , 2004, Circulation.
[22] N. Mackman. Role of tissue factor in hemostasis, thrombosis, and vascular development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[23] Martin J. Lohse,et al. Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy , 2004 .
[24] R. Pijnenborg,et al. Trophoblast and the endometrium--a workshop report. , 2004, Placenta.
[25] K. Lim,et al. Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.
[26] Roland Jahns,et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. , 2004, The Journal of clinical investigation.
[27] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.
[28] G. Wallukat,et al. AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase , 2003, Circulation.
[29] S. Bobst,et al. Maternal Autoantibodies From Preeclamptic Patients Active Angiotensin Receptors on Human Trophoblast Cells , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.
[30] J. Cutler,et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy , 2003, Hypertension in pregnancy.
[31] H. Lother,et al. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.
[32] J. Granger,et al. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. , 2001, Hypertension.
[33] D. Ganten,et al. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. , 2000, Journal of the American Society of Nephrology : JASN.
[34] James J. Walker,et al. Pre-eclampsia , 2000, The Lancet.
[35] R. Ansari,et al. Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. , 2000, Hypertension.
[36] G. Wallukat,et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension , 2000, Journal of hypertension.
[37] G. Wallukat,et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. , 2000, Circulation.
[38] J. Chirgwin,et al. REPRODUCTIVE TISSUE RENIN GENE EXPRESSION IN PREECLAMPSIA , 2000, Hypertension in pregnancy.
[39] M. Faas,et al. Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.
[40] G. Wallukat,et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. , 1999, The Journal of clinical investigation.
[41] I. Sargent,et al. Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.
[42] J. Lalouel,et al. Angiotensinogen T235 expression is elevated in decidual spiral arteries. , 1997, The Journal of clinical investigation.
[43] R. Schmieder,et al. Preeclampsia -- a state of sympathetic overactivity. , 1996, The New England journal of medicine.
[44] A. Fukamizu,et al. Hypertension Induced in Pregnant Mice by Placental Renin and Maternal Angiotensinogen , 1996, Science.
[45] M. Faas,et al. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. , 1994, American journal of obstetrics and gynecology.
[46] J. Lalouel,et al. A molecular variant of angiotensinogen associated with preeclampsia , 1993, Nature Genetics.